{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T13:45:35Z","timestamp":1791985535475,"version":"4.4.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Histol"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s10735-026-11005-9","type":"journal-article","created":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T12:52:34Z","timestamp":1791982354000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparison of the efficacy of TXNDC5 monoclonal antibody versus conventional drugs in the treatment of intestinal fibrosis associated with inflammatory bowel disease"],"prefix":"10.1007","volume":"57","author":[{"given":"Jiawei","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianghui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,14]]},"reference":[{"key":"11005_CR1","doi-asserted-by":"publisher","first-page":"765474","DOI":"10.3389\/fmed.2021.765474","volume":"8","author":"Z Cai","year":"2021","unstructured":"Cai Z, Wang S, Li J (2021) Treatment of inflammatory bowel disease: a comprehensive review. Front Med (Lausanne) 8:765474","journal-title":"Front Med (Lausanne)"},{"key":"11005_CR2","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1080\/10520295.2023.2176923","volume":"98","author":"M Cellat","year":"2023","unstructured":"Cellat M et al (2023) Inula viscosa ameliorates acetic acid induced ulcerative colitis in rats. Biotech Histochem 98:255\u2013266","journal-title":"Biotech Histochem"},{"key":"11005_CR3","doi-asserted-by":"publisher","first-page":"e143645","DOI":"10.1172\/JCI143645","volume":"131","author":"Y-T Chen","year":"2021","unstructured":"Chen Y-T et al (2021) Endoplasmic reticulum protein TXNDC5 promotes renal fibrosis by enforcing TGF-\u03b2 signaling in kidney fibroblasts. J Clin Invest 131:e143645","journal-title":"J Clin Invest"},{"key":"11005_CR4","doi-asserted-by":"publisher","first-page":"7202","DOI":"10.1038\/s41467-026-74073-1","volume":"17","author":"K-L Cheng","year":"2026","unstructured":"Cheng K-L et al (2026) Targeting fibroblast TXNDC5 resolves tumor desmoplasia and PD-1 resistance in colorectal cancer with mesenchymal traits. Nat Commun 17:7202","journal-title":"Nat Commun"},{"key":"11005_CR5","first-page":"238","volume":"69","author":"HS Cooper","year":"1993","unstructured":"Cooper HS, Murthy SN, Shah RS, Sedergran DJ (1993) Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest 69:238\u2013249","journal-title":"Lab Invest"},{"key":"11005_CR6","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1002\/iid3.321","volume":"8","author":"B Creyns","year":"2020","unstructured":"Creyns B et al (2020) Fibrogenesis in chronic murine colitis is independent of innate lymphoid cells. Immun Inflam Disease 8:393\u2013407","journal-title":"Immun Inflam Disease"},{"key":"11005_CR7","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1093\/ecco-jcc\/jjv133","volume":"9","author":"JR De Bruyn","year":"2015","unstructured":"De Bruyn JR et al (2015) Development of fibrosis in acute and longstanding ulcerative colitis. ECCOJC 9:966\u2013972","journal-title":"ECCOJC"},{"key":"11005_CR8","doi-asserted-by":"publisher","first-page":"9318721","DOI":"10.1155\/2022\/9318721","volume":"2022","author":"L Deng","year":"2022","unstructured":"Deng L et al (2022) The attenuation of chronic ulcerative colitis by (R)-salbutamol in repeated DSS\u2010induced mice. Oxidative Med Cell Longev 2022:9318721","journal-title":"Oxidative Med Cell Longev"},{"key":"11005_CR9","doi-asserted-by":"publisher","first-page":"4060","DOI":"10.3390\/jcm14124060","volume":"14","author":"FS Fousekis","year":"2025","unstructured":"Fousekis FS et al (2025) Intestinal fibrosis in crohn\u2019s disease: pathophysiology, diagnosis, and new therapeutic targets. J Clin Med 14:4060","journal-title":"J Clin Med"},{"key":"11005_CR10","doi-asserted-by":"publisher","first-page":"15182","DOI":"10.1038\/s41598-018-33452-5","volume":"8","author":"A H\u00fcnerwadel","year":"2018","unstructured":"H\u00fcnerwadel A et al (2018) Severity of local inflammation does not impact development of fibrosis in mouse models of intestinal fibrosis. Sci Rep 8:15182","journal-title":"Sci Rep"},{"key":"11005_CR11","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/j.crohns.2014.03.008","volume":"8","author":"G Latella","year":"2014","unstructured":"Latella G et al (2014) Results of the 4th scientific workshop of the ECCO (I): pathophysiology of intestinal fibrosis in IBD. J Crohns Colitis 8:1147\u20131165","journal-title":"J Crohns Colitis"},{"key":"11005_CR12","doi-asserted-by":"publisher","first-page":"4254","DOI":"10.1038\/s41467-020-18047-x","volume":"11","author":"T-H Lee","year":"2020","unstructured":"Lee T-H et al (2020) Fibroblast-enriched endoplasmic reticulum protein TXNDC5 promotes pulmonary fibrosis by augmenting TGF\u03b2 signaling through TGFBR1 stabilization. Nat Commun 11:4254","journal-title":"Nat Commun"},{"key":"11005_CR13","doi-asserted-by":"publisher","first-page":"101251","DOI":"10.1016\/j.mam.2024.101251","volume":"96","author":"MV Lenti","year":"2024","unstructured":"Lenti MV, Santacroce G, Broglio G, Rossi CM (2024) Recent advances in intestinal fibrosis. Mol Aspects Med 96:101251","journal-title":"Mol Aspects Med"},{"key":"11005_CR14","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1161\/CIRCRESAHA.117.312130","volume":"122","author":"Y-C Shih","year":"2018","unstructured":"Shih Y-C et al (2018) Endoplasmic reticulum protein TXNDC5 augments myocardial fibrosis by facilitating extracellular matrix protein folding and redox-sensitive cardiac fibroblast activation. Circ Res 122:1052\u20131068","journal-title":"Circ Res"},{"key":"11005_CR15","doi-asserted-by":"crossref","unstructured":"Tekeli \u0130O et al (2018) Protective effects of conventional and colon-targeted lycopene and linalool on ulcerative colitis induced by acetic acid in rats. Inflammopharmacology","DOI":"10.1007\/s10787-018-0485-x"},{"key":"11005_CR16","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/cmi.2017.20","volume":"15","author":"L Wang","year":"2018","unstructured":"Wang L et al (2018) TXNDC5 synergizes with HSC70 to exacerbate the inflammatory phenotype of synovial fibroblasts in rheumatoid arthritis through NF-\u03baB signaling. Cell Mol Immunol 15:685\u2013696","journal-title":"Cell Mol Immunol"},{"key":"11005_CR17","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/imr.12974","volume":"302","author":"J Wang","year":"2021","unstructured":"Wang J et al (2021) Novel mechanisms and clinical trial endpoints in intestinal fibrosis. Immunol Rev 302:211\u2013227","journal-title":"Immunol Rev"}],"container-title":["Journal of Molecular Histology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10735-026-11005-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10735-026-11005-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10735-026-11005-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T12:52:36Z","timestamp":1791982356000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10735-026-11005-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,14]]},"references-count":17,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["11005"],"URL":"https:\/\/doi.org\/10.1007\/s10735-026-11005-9","relation":{},"ISSN":["1567-2379","1567-2387"],"issn-type":[{"value":"1567-2379","type":"print"},{"value":"1567-2387","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,14]]},"assertion":[{"value":"24 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interest.","order":1,"name":"Ethics","label":"Competing interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"337"}}